Literature DB >> 26714802

The influence of multilevel upper airway surgery on CPAP tolerance in non-responders to obstructive sleep apnea surgery.

Sule Azbay1, Asli Bostanci2, Yasin Aysun1, Murat Turhan1.   

Abstract

The aim of this study was to evaluate the influence of multilevel upper airway surgery on subsequent continuous positive airway pressure (CPAP) use and tolerance in patients with moderate to severe obstructive sleep apnea (OSA). The study cohort enrolled 67 consecutive patients, who underwent septoplasty plus modified uvulopharyngopalatoplasty (mUPPP) with or without modified tongue base suspension (mTBS) due to CPAP intolerance, and who had residual OSA requiring CPAP therapy [non-responders to surgery, apnea-hypopnea index (AHI) >15 events/h] that had been confirmed by control polysomnography at the sixth month postoperatively. A questionnaire including questions on postoperative CPAP use, problems faced during CPAP use after the surgery, change in OSA symptoms, and satisfaction with the surgery was designed, and filled through interviews. Seventeen (25.4 %) patients had septoplasty plus mUPPP and 50 (74.6 %) had septoplasty plus mUPPP combined with mTBS. Postoperatively, mean AHI (45.00 ± 19.76 vs. 36.60 ± 18.34), Epworth sleepiness scale (ESS) score (18.00 ± 4.45 vs. 13.00 ± 4.72), oxygen desaturation index (ODI) (48.98 ± 16.73 vs. 37.81 ± 17.03), and optimal CPAP level (11.80 ± 1.40 vs. 8.96 ± 1.20) were decreased (p < 0.001 for all parameters). Fifty-nine percent of patients reported that they fairly satisfied with the surgery and 49.2 % reported that their symptoms were completely resolved. While none of the cases could tolerate CPAP before surgery, almost half (47.8 %) of the cases used CPAP without problems postoperatively. Postoperative CPAP users had significantly higher postoperative AHI (p = 0.001), supine AHI (p = 0.009), ESS (p = 0.019), and ODI (p = 0.014), and significantly lower postoperative minimum O2 saturation (p = 0.001) compared with non-users. Multilevel upper airway surgery with less invasive techniques may improve CPAP tolerance in well-selected patients.

Entities:  

Keywords:  CPAP; Multilevel surgery; OSA; Tolerance

Mesh:

Year:  2015        PMID: 26714802     DOI: 10.1007/s00405-015-3865-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  Influence of UPPP surgery on tolerance to subsequent continuous positive airway pressure in patients with OSAHS.

Authors:  Fang Han; Wengcai Song; Jing Li; Lihong Zhang; Xiaosong Dong; Quanying He
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

Review 2.  Positive pressure therapy: a perspective on evidence-based outcomes and methods of application.

Authors:  Mark H Sanders; Josep M Montserrat; Ramon Farré; Rachel J Givelber
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

3.  Upper airway surgery does not have a major role in the treatment of sleep apnea. Con.

Authors:  Barbara Phillips
Journal:  J Clin Sleep Med       Date:  2005-07-15       Impact factor: 4.062

4.  Tongue base suspension combined with UPPP in severe OSA patients.

Authors:  Mehmet Omur; Dilaver Ozturan; Feyzi Elez; Celal Unver; Sabri Derman
Journal:  Otolaryngol Head Neck Surg       Date:  2005-08       Impact factor: 3.497

5.  Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome.

Authors:  I L Mortimore; P A Bradley; J A Murray; N J Douglas
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

6.  CPAP treatment in obstructive sleep apnoea: a randomised, controlled trial of follow-up with a focus on patient satisfaction.

Authors:  C Holmdahl; I-L Schöllin; M Alton; K Nilsson
Journal:  Sleep Med       Date:  2009-01-28       Impact factor: 3.492

7.  The impact of modified tongue base suspension on CPAP levels in patients with severe OSA.

Authors:  Murat Turhan; Asli Bostanci; Mehmet Akdag
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-11       Impact factor: 2.503

Review 8.  Adult obstructive sleep apnoea.

Authors:  Amy S Jordan; David G McSharry; Atul Malhotra
Journal:  Lancet       Date:  2013-08-02       Impact factor: 79.321

Review 9.  Role of surgery in adult obstructive sleep apnoea.

Authors:  Bhik T Kotecha; Andy C Hall
Journal:  Sleep Med Rev       Date:  2014-02-15       Impact factor: 11.609

10.  Modified uvulopalatopharyngoplasty for the treatment of obstructive sleep apnea-hypopnea syndrome: resection of the musculus uvulae.

Authors:  Seung-Heon Shin; Mi-Kyung Ye; Chang-Gyun Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2009-04-05       Impact factor: 3.497

View more
  5 in total

1.  The predictive value of drug-induced sleep endoscopy for CPAP titration in OSA patients.

Authors:  Ming-Chin Lan; Yen-Bin Hsu; Ming-Ying Lan; Yun-Chen Huang; Ming-Chang Kao; Tung-Tsun Huang; Tsan-Jen Chiu; Mei-Chen Yang
Journal:  Sleep Breath       Date:  2017-12-15       Impact factor: 2.816

2.  Upper airway surgery to rescue the "untitratable" patient with OSA and obesity.

Authors:  Everett G Seay; Graeme Mulholland; Raj C Dedhia
Journal:  J Clin Sleep Med       Date:  2019-11-27       Impact factor: 4.062

3.  Combined Surgical Approach for Obstructive Sleep Apnea Patient.

Authors:  Mahmoud A K Ebrahim; Osamah AlSanea; Abdulmohsen E Al-Terki
Journal:  Case Rep Otolaryngol       Date:  2018-03-28

Review 4.  Intrapharyngeal surgery with integrated treatment for obstructive sleep apnea.

Authors:  Hsueh-Yu Li; Li-Ang Lee; Li-Jen Hsin; Tuan-Jen Fang; Wan-Ni Lin; Hung-Chin Chen; Yi-An Lu; Yi-Chan Lee; Ming-Shao Tsai; Yao-Te Tsai
Journal:  Biomed J       Date:  2019-05-02       Impact factor: 4.910

5.  Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  David Kent; Jeffrey Stanley; R Nisha Aurora; Corinna G Levine; Daniel J Gottlieb; Matthew D Spann; Carlos A Torre; Katherine Green; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.